Ledger.Open graph →
SEC Form D · filed April 1, 2016

Atrin Pharmaceuticals LLC

Offering
$2.0M
Sold
$1.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DOYLESTOWN, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Oren Gilad · Doylestown, PAExec · Director · PromoterBernard C. Rudnick · Doylestown, PAExec · DirectorCharles Smith · Denver, COExec · DirectorPeter J. Ogren · Burlington, MAExec · Director · PromoterSusan D. Sarandon · New York, NYExec · DirectorLou D. Canakes Ii · New York, NYExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗